comparemela.com

Latest Breaking News On - Namodenoson treatment for pancreatic and liver cancer - Page 1 : comparemela.com

Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference Seite 1

11.03.2024 - Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business Development, Dr. Sari . Seite 1

Sari-fishman
Vp-business-development-at-can
Bio-europe-conference
Namodenoson-treatment-for-pancreatic-and-liver-cancer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.